相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy
Tuxiong Huang et al.
CANCER COMMUNICATIONS (2020)
Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/-catenin signaling pathway by regulating WNT2
Dian-Hui Xiu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Pengfei Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Fibroblast Growth Factor Receptor Signaling in Skin Cancers
Malgorzata Czyz
CELLS (2019)
The immune landscape of esophageal cancer
Tu-Xiong Huang et al.
CANCER COMMUNICATIONS (2019)
Paracrine Wnt5a-beta-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization
Fei Zhao et al.
IMMUNITY (2018)
Targeting Wnt/β-Catenin Signaling for Cancer Immunotheraoy
Bojun Wang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer
Anuradha Krishnamurthy et al.
CANCER RESEARCH (2018)
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
[Anonymous]
NATURE REVIEWS DRUG DISCOVERY (2018)
Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression
N. Kramer et al.
ONCOGENE (2017)
The non-canonical Wnt pathway negatively regulates dendritic cell differentiation by inhibiting the expansion of Flt3+ lymphocyte-primed multipotent precursors
Jing Xiao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Coinhibitory Pathways in Immunotherapy for Cancer
Susanne H. Baumeister et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
Kamal Ahmed et al.
CANCERS (2016)
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W. L. Teng et al.
CANCER RESEARCH (2015)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells
Tuxiong Huang et al.
PATHOGENS AND DISEASE (2015)
SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer
Yi Li et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
WNT2 promoter methylation in human placenta is associated with low birthweight percentile in the neonate
Jose C. Ferreira et al.
EPIGENETICS (2011)
Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway
Li Fu et al.
GUT (2011)
Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model
Yuan Wen et al.
CANCER SCIENCE (2010)
Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function
Jessica A. Meliilo et al.
JOURNAL OF IMMUNOLOGY (2010)
Bone Marrow Derived Dendritic Cells are More Suitable Than Dendritic Cell Line DC2.4 to Study Tumor-Mediated Suppression of DC Maturation Through STAT3 Hyperactivation
Aws Alshamsan et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2010)
Loss of Jak2 Selectively Suppresses DC-Mediated Innate Immune Response and Protects Mice from Lethal Dose of LPS-Induced Septic Shock
Jixin Zhong et al.
PLOS ONE (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
Signaling from Fibroblast Growth Factor Receptor 2 in Immature Hematopoietic Cells Facilitates Donor Hematopoiesis After Intra-Bone Marrow-Bone Marrow Transplantation
Akio Shigematsu et al.
STEM CELLS AND DEVELOPMENT (2010)
Fibroblast Growth Factor Receptor 2-Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma
Chunyu Zhang et al.
CLINICAL CANCER RESEARCH (2009)
Notch and Wingless Signaling Cooperate in Regulation of Dendritic Cell Differentiation
Jie Zhou et al.
IMMUNITY (2009)
Fibroblast growth factor-2 and its receptor expression in proliferating precursor cells of the subventricular zone in the adult rat brain
Monica Frinchi et al.
NEUROSCIENCE LETTERS (2008)
WNT signalling in the immune system: WNT is spreading its wings
Frank J. T. Staal et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo
Yonghai Li et al.
JOURNAL OF IMMUNOLOGY (2006)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Wnt5a regulates Shh and Fgf10 signaling during lung development
CG Li et al.
DEVELOPMENTAL BIOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
The Wnt signaling pathway in development and disease
CY Logan et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Wnt5a participates in distal lung morphogenesis
CG Li et al.
DEVELOPMENTAL BIOLOGY (2002)
分享论文
